CA2160922C - Complexes immunogenes pour la detection du hiv - Google Patents

Complexes immunogenes pour la detection du hiv Download PDF

Info

Publication number
CA2160922C
CA2160922C CA002160922A CA2160922A CA2160922C CA 2160922 C CA2160922 C CA 2160922C CA 002160922 A CA002160922 A CA 002160922A CA 2160922 A CA2160922 A CA 2160922A CA 2160922 C CA2160922 C CA 2160922C
Authority
CA
Canada
Prior art keywords
complex
hiv
antibodies
covalently bonded
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002160922A
Other languages
English (en)
Other versions
CA2160922A1 (fr
Inventor
Anthony Louis De Vico
Ranajit Pal
Mangalasseril Gopalau Sarngadharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Priority claimed from PCT/US1994/005020 external-priority patent/WO1994026305A1/fr
Publication of CA2160922A1 publication Critical patent/CA2160922A1/fr
Application granted granted Critical
Publication of CA2160922C publication Critical patent/CA2160922C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
CA002160922A 1993-05-07 1994-05-06 Complexes immunogenes pour la detection du hiv Expired - Lifetime CA2160922C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6092693A 1993-05-07 1993-05-07
US08/060,926 1993-05-07
PCT/US1994/005020 WO1994026305A1 (fr) 1993-05-07 1994-05-06 Complexes immunogenes de v.i.h.

Publications (2)

Publication Number Publication Date
CA2160922A1 CA2160922A1 (fr) 1994-11-24
CA2160922C true CA2160922C (fr) 2007-03-13

Family

ID=38007959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002160922A Expired - Lifetime CA2160922C (fr) 1993-05-07 1994-05-06 Complexes immunogenes pour la detection du hiv

Country Status (1)

Country Link
CA (1) CA2160922C (fr)

Also Published As

Publication number Publication date
CA2160922A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
EP0699077B1 (fr) Complexes immunogenes de v.i.h.
Thali et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
CA2268372C (fr) Compositions et procedes destines au traitement d'infections virales
Thali et al. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein
Dalgleish et al. Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide
Wyatt et al. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region
Thali et al. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events
Pinter et al. Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1V2 domain of HIV-1 gp120
EP1016671A2 (fr) Anticorps monoclonaux humains contre la glycoprotéine transmembranaire (gp41) de HIV-1, et peptides associés
Matsushita et al. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120
CA2160922C (fr) Complexes immunogenes pour la detection du hiv
Pal et al. Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1
Viveros et al. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41
EP1638996A1 (fr) Complexes immunogenes de vih
Neurath B Cell Antigenic Site Mapping of HIV-1 Glycoproteins¹
EP0400245B1 (fr) Protéines et glycoprotéines du retrovirus HIV-2 EHO, anticorps dirigés contre eux, application pour le diagnostic
AU2006200454A1 (en) Compositions and methods for treating viral infections
AU2008203501A1 (en) Compositions and methods for treating viral infections
AU2006200455A1 (en) Compositions and methods for treating viral infections
HK212896A (en) Proteins and glycoproteins of the hiv-2 eho retrovirus antibodies directed against them - application for the diagnosis
AU2004208648A1 (en) Compositions and methods for treating infections

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140506